Be part of a first-in-the-world clinical trial testing epigenetic silencing technology.
Epigenetic gene silencing has the potential to achieve lasting control of HepB infection following a single, one-time treatment. No cutting or gene-editing required.
Find out if this trial is right for you.
Hoplink to https://www.hepatitisfoundation.org.nz/clinical-trials/ to find out more.
